Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,504 signal articles · 137 in last 24h · 154,538 total before filter · latest 50m ago
137last 24h
848last 7d
143● bullish (7d)
88● bearish (7d)
214publishers
AllMacro194Earnings105M&A124Regulatory18Product22Analyst20
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Broadcom (AVGO) Is Up 7.4% After Massive Buybacks And AI Chip Deals With Hyperscalers - Has The Bull Case Changed?
Simply Wall St.2d agobullish
Broadcom (AVGO) Is Up 7.4% After Massive Buybacks And AI Chip Deals With Hyperscalers - Has The Bull Case Changed?

In the past few weeks, Broadcom reported that it completed a multi-year share repurchase program totaling 41,000,000 shares for about US$10.93 billion, alongside launching a fixed-income exchange offer for its US$654.00 million 4.926% Notes due 2037. At the same time, management highlighted that AI semiconductors now generate more than half of Broadcom’s sales, supported by long-term commitments from hyperscale customers such as Anthropic, Alphabet, and Meta. We’ll now examine how Broadcom’s...

Moderna (MRNA) Stock Looks Very Expensive As Shares Surge Over 1 Year
Simply Wall St.2d agobullish
Moderna (MRNA) Stock Looks Very Expensive As Shares Surge Over 1 Year

Moderna has delivered a very large 1 year share price gain, which puts fresh attention on a basic question. Is the current valuation of the stock supported by the company’s sales profile rather than just recent momentum and headlines? The stock is up a very large amount over the past 12 months, which makes the link between Moderna’s market value and its underlying sales more important for anyone thinking about valuation risk. News around mRNA products, from the mFlusiva flu vaccine launch to...

Meta doesn't need the best AI model — it has something better: you.

While OpenAI and Anthropic compete on raw model performance, Meta's new agent wins on data. They know what you want to buy before you do, and now they can finally act on it, cutting out the middlemen and becoming the marketplace itself.

Would you actually use an AI agent that knows you this well?

Watch the full episode, In The Loop, on Youtube.
Yahoo Finance Video2d agobullishVIDEO
Meta doesn't need the best AI model — it has something better: you. While OpenAI and Anthropic compete on raw model performance, Meta's new agent wins on data. They know what you want to buy before you do, and now they can finally act on it, cutting out the middlemen and becoming the marketplace itself. Would you actually use an AI agent that knows you this well? Watch the full episode, In The Loop, on Youtube.

Meta doesn't need the best AI model — it has something better: you. While OpenAI and Anthropic compete on raw model performance, Meta's new agent wins on data. They know what you want to buy before you do, and now they can finally act on it, cutting out the middlemen and becoming the marketplace itself. Would you actually use an AI agent that knows you this well? Watch the full episode, In The Loop, on Youtube.

Fastly Targets Up to $1.3B Revenue by 2029 as AI Traffic Surges
MarketBeat2d agobullish
Fastly Targets Up to $1.3B Revenue by 2029 as AI Traffic Surges

Fastly (NASDAQ:FSLY) outlined a strategy centered on expanding its unified edge cloud platform, increasing multi-product adoption, broadening its geographic reach and targeting revenue of $1.1 billion to $1.3 billion by 2029 at its Investor Day. Chief Executive Officer Kip Compton said the company

Microchip (MCHP) Closes its Hailo Deal. Why the Chipmaker is Buying Edge AI on the Cheap
Insider Monkey2d agobullish
Microchip (MCHP) Closes its Hailo Deal. Why the Chipmaker is Buying Edge AI on the Cheap

Microchip Technology Incorporated (NASDAQ:MCHP) said on September 21 that it has completed its acquisition of Hailo. The Israeli company makes processors that run AI on devices rather than in the cloud, covering vision, robotics and what the industry calls physical AI. Microchip did not disclose the price. It said the deal will not have a […]

AbbVie (ABBV) Wins EU Approval for Rinvoq in Children. Why a Small Indication Still Matters
Insider Monkey2d agobullish
AbbVie (ABBV) Wins EU Approval for Rinvoq in Children. Why a Small Indication Still Matters

AbbVie Inc. (NYSE:ABBV) said on September 22 that the European Commission has approved Rinvoq for children aged two and older with active polyarticular juvenile idiopathic arthritis. The approval covers patients who did not respond to, or could not tolerate, standard disease-modifying drugs. It is the eleventh indication Rinvoq holds in Europe. The Commission also cleared […]

On Holding (ONON) Approves a $1 Billion Buyback Alongside its 2029 Targets
Insider Monkey2d agobullish
On Holding (ONON) Approves a $1 Billion Buyback Alongside its 2029 Targets

On Holding AG (NYSE:ONON) set out new long-term targets at its investor day in Zurich on September 22. The Swiss sportswear maker wants net sales of at least CHF 5.6 billion by 2029, from a high-teens annual growth rate in constant currency. Its board also authorised the company’s first share buyback, worth up to $1 […]